Cargando…
Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation
OBJECTIVE: Prevention of recurrent stroke in patients with embolic stroke of undetermined source (ESUS) is challenging. The advent of safer anticoagulation in the form of direct oral anticoagulants (DOACs) has prompted exploration of prophylactic anticoagulation for all ESUS patients, rather than an...
Autores principales: | Witte, Klaus K., Tsivgoulis, Georgios, Reynolds, Matthew R., Tsintzos, Stelios I., Eggington, Simon, Ismyrloglou, Eleni, Lyon, Julie, Huynh, Marianne, Egea, Marta, de Brouwer, Bonnie, Ziegler, Paul D., Franco, Noreli, Joglekar, Rashmi, Rosemas, Sarah C., Liu, Shufeng, Thijs, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015049/ https://www.ncbi.nlm.nih.gov/pubmed/33789592 http://dx.doi.org/10.1186/s12872-021-01967-x |
Ejemplares similares
-
Economic value of insertable cardiac monitors in unexplained syncope in the United States
por: Sutton, Brad S, et al.
Publicado: (2021) -
Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the US
por: Elkind, Mitchell S. V., et al.
Publicado: (2023) -
Embolic stroke of undetermined source: identification of patient subgroups for oral anticoagulation treatment
por: Greeve, Isabell, et al.
Publicado: (2021) -
Financial impact of adopting implantable loop recorder diagnostic for unexplained syncope compared with conventional diagnostic pathway in Portugal
por: Providência, Rui, et al.
Publicado: (2014) -
Healthcare utilization and clinical outcomes after ablation of atrial fibrillation in patients with and without insertable cardiac monitoring
por: Mansour, Moussa C., et al.
Publicado: (2022)